Oxcarbazepine

CAS 28721-07-5 27 API suppliersSmall Molecule

Overview

Oxcarbazepine is an anticonvulsant and mood-stabilizing drug, used primarily in the treatment of epilepsy. It works by blocking sodium channels and stabilizing hyperexcited nerve cell membranes.

API suppliers (27)

Suppliers of Oxcarbazepine evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India7Italy3China2Israel1

Country recorded for 13 of 27 suppliers.

12 of 27 hold a GMP certificate on record in the EU or UK registers

Showing 25 of 27 suppliers — see the full list in the app.

Patent & exclusivity (US)

Per the FDA Orange Book (59 approved US products), the latest listed US patent on Oxcarbazepine expires 13 Apr 2027. Generic API sourcing typically opens up once these lapse.

Therapeutic areas

NeurologyPsychiatry
Verified Supplier Partner

Do you supply Oxcarbazepine? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.